Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression
Oncotarget (2015) - Comments
pubmed: 26009876  doi: 10.18632/oncotarget.4105  issn: 1949-2553 

Haolong Li, Ning Xie, Martin E. Gleave, Xuesen Dong